Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Max W. F. van Spengler"'
Autor:
Max W. F. van Spengler, Laura H. Bukkems, Ron A. A. Mathôt, Tim Preijers, Marjon H. Cnossen, Frank W.G. Leebeek
Publikováno v:
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, 77(8), 1193-1200. Springer-Verlag
European journal of clinical pharmacology, 77(8), 1193-1200. Springer Verlag
European Journal of Clinical Pharmacology, 77(8), 1193-1200. Springer-Verlag
European journal of clinical pharmacology, 77(8), 1193-1200. Springer Verlag
Purpose Pharmacokinetic (PK) differences between the extended half-life (EHL) factor IX (FIX) concentrates for hemophilia B exist, which may influence hemostatic efficacy of replacement therapy in patients. Therefore, we aimed to evaluate the PK prop
Autor:
Marjon H. Cnossen, Ron A. A. Mathôt, Tim Preijers, Frank W.G. Leebeek, Laura H. Bukkems, Max W. F. van Spengler
Publikováno v:
Thrombosis and haemostasis, 121(6), 731-740. Schattauer GmbH
Thrombosis and Haemostasis, 121(6), 731-740. Georg Thieme Verlag
Thrombosis and Haemostasis, 121(6), 731-740. Georg Thieme Verlag
Background The pharmacokinetic (PK) properties of extended half-life (EHL) factor VIII (FVIII) concentrates differ, leading to variation in the optimal dosing regimen for the individual patient. The aim of this study was to establish these PK differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d856c142beefbde4674c18c0c9d413c
https://pure.amc.nl/en/publications/comparison-of-the-pharmacokinetic-properties-of-extended-halflife-and-recombinant-factor-viii-concentrates-by-in-silico-simulations(58dc08e2-e918-4711-8b3e-dd58a33e6136).html
https://pure.amc.nl/en/publications/comparison-of-the-pharmacokinetic-properties-of-extended-halflife-and-recombinant-factor-viii-concentrates-by-in-silico-simulations(58dc08e2-e918-4711-8b3e-dd58a33e6136).html